TC Biopharm (Holdings) Plc (TCBP)

TC Biopharm (Holdings) Statistics

Total Valuation

TCBP has a market cap or net worth of $3.11 million. The enterprise value is $3.93 million.

Market Cap	3.11M
Enterprise Value	3.93M

Important Dates

The last earnings date was Monday, November 25, 2024, after market close.

Earnings Date	Nov 25, 2024
Ex-Dividend Date	n/a

Share Statistics

TCBP has 8.21 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.21M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+230.71%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	0.46%
Float	8.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.07
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.83.

Current Ratio	1.12
Quick Ratio	0.64
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-142.89

Financial Efficiency

Return on equity (ROE) is -577.04% and return on invested capital (ROIC) is -182.74%.

Return on Equity (ROE)	-577.04%
Return on Assets (ROA)	-98.20%
Return on Capital (ROIC)	-182.74%
Revenue Per Employee	n/a
Profits Per Employee	-$356,739
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-764,918
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.64% in the last 52 weeks. The beta is -0.13, so TCBP's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-96.64%
50-Day Moving Average	0.36
200-Day Moving Average	3.33
Relative Strength Index (RSI)	50.26
Average Volume (20 Days)	4,652,203

Short Selling Information

Short Interest	145,109
Short Previous Month	31,608
Short % of Shares Out	1.77%
Short % of Float	1.77%
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.99M
Pretax Income	n/a
Net Income	-14.63M
EBITDA	-14.32M
EBIT	-14.99M
Earnings Per Share (EPS)	-$78.81

Balance Sheet

The company has $1.27 million in cash and $2.09 million in debt, giving a net cash position of -$820,451 or -$0.10 per share.

Cash & Cash Equivalents	1.27M
Total Debt	2.09M
Net Cash	-820,451
Net Cash Per Share	-$0.10
Equity (Book Value)	2.53M
Book Value Per Share	5.12
Working Capital	535,665

Cash Flow

In the last 12 months, operating cash flow was -$11.17 million and capital expenditures $34,950, giving a free cash flow of -$10.73 million.

Operating Cash Flow	-11.17M
Capital Expenditures	34,950
Free Cash Flow	-10.73M
FCF Per Share	-$1.31

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-470.18%
FCF Yield	-344.85%

Analyst Forecast

The average price target for TCBP is $2.40, which is 533.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.40
Price Target Difference	533.25%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 7, 2025. It was a forward split with a ratio of 1.25:1.

Last Split Date	Jan 7, 2025
Split Type	Forward
Split Ratio	1.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1